Anson Funds Management LP Sellas Life Sciences Group, Inc. Transaction History
Anson Funds Management LP
- $605 Million
- Q3 2025
A detailed history of Anson Funds Management LP transactions in Sellas Life Sciences Group, Inc. stock. As of the latest transaction made, Anson Funds Management LP holds 6,032,938 shares of SLS stock, worth $8.63 Million. This represents 1.59% of its overall portfolio holdings.
Number of Shares
6,032,938
Previous 275,000
2093.8%
Holding current value
$8.63 Million
Previous $602,000
1503.32%
% of portfolio
1.59%
Previous 0.11%
Shares
6 transactions
Others Institutions Holding SLS
# of Institutions
100Shares Held
27.8MCall Options Held
3.85MPut Options Held
126K-
Vanguard Group Inc Valley Forge, PA6.84MShares$9.78 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.36MShares$3.37 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.26MShares$3.24 Million0.0% of portfolio
-
State Street Corp Boston, MA1.36MShares$1.95 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.05MShares$1.51 Million0.0% of portfolio
About SELLAS Life Sciences Group, Inc.
- Ticker SLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,551,900
- Market Cap $29.4M
- Description
- SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...